Abstract
Inequalities in features and severity of ankylosing spondylitis (AS) have been noticed between men and women, suggesting a possible influence of gender on disease phenotypes. Comparing disease features and characterization of gender differences in clinical features and medications could help elucidate the potential influence of gender on the severity of AS in patients. This study aims to assess the influence of gender on disease patterns in Iranian patients with AS. Three hundred and twenty patients diagnosed with primary AS were assessed for demographic variables, clinical manifestations, HLA status, disease severity, functional capacities, quality of life, and treatment status. Sixty-seven women and 253 men were included corresponding to a male to female ratio of 3.78:1. Both groups were similar regarding ethnicity, positive family history, and juvenile onset AS. HLA-B27 was more frequent among males (78.3 vs. 55.2 %; p < 0.001). There was a higher proportion of female patients with overall enthesitis (p < 0.05). Extra-articular manifestations and treatment modalities presented similar frequencies in both genders. No difference in gender-associated diagnostic delays was observed. Female disease was at least as severe as male disease, and in some aspects, females presented with more severe disease. Despite a relatively similar disease profile, we observed a higher rate of enthesitis among women. Together with the equally high rate of disease activity indices in both genders, these findings indicate an overall longer delay to diagnosis in our country. Early detection and specialized care would be of great practical importance.
Similar content being viewed by others
References
Lee W, Reveille JD, Davis JC Jr, Learch TJ, Ward MM, Weisman MH (2007) Are there gender differences in severity of ankylosing spondylitis? Results from the PSOAS cohort. Ann Rheum Dis 66(5):633–638
Ankylosing Spondylitis Society in Iran. Ankylosing Spondylitis International Federation (ASIF). http://www.asif.rheumanet.org/iran.htm. Accessed December 24 2012
van der Linden S, Valkenburg HA, Cats A (1984) Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria. Arthritis Rheum 27(4):361–368
Feldtkeller E, Erlendsson J (2008) Definition of disease duration in ankylosing spondylitis. Rheumatol Int 28(7):693–696
van der Heijde D, van der Linden S, Bellamy N, Calin A, Dougados M, Khan MA (1999) Which domains should be included in a core set for endpoints in ankylosing spondylitis? Introduction to the ankylosing spondylitis module of OMERACT IV. J Rheumatol 26(4):945–947
Garrett S, Jenkinson T, Kennedy LG, Whitelock H, Gaisford P, Calin A (1994) A new approach to defining disease status in ankylosing spondylitis: the Bath Ankylosing Spondylitis Disease Activity Index. J Rheumatol 21(12):2286–2291
Calin A, Garrett S, Whitelock H, Kennedy LG, O'Hea J, Mallorie P, Jenkinson T (1994) A new approach to defining functional ability in ankylosing spondylitis: the development of the Bath Ankylosing Spondylitis Functional Index. J Rheumatol 21(12):2281–2285
Jones SD, Porter J, Garrett SL, Kennedy LG, Whitelock H, Calin A (1995) A new scoring system for the Bath Ankylosing Spondylitis Metrology Index (BASMI). J Rheumatol 22(8):1609
Jones SD, Steiner A, Garrett SL, Calin A (1996) The Bath Ankylosing Spondylitis Patient Global Score (BAS-G). Br J Rheumatol 35(1):66–71
Bidad K, Fallahi S, Mahmoudi M, Jamshidi A, Farhadi E, Meysamie A, Nicknam MH (2011) Evaluation of the Iranian versions of the bath ankylosing spondylitis disease activity index (BASDAI), the bath ankylosing spondylitis functional index (BASFI) and the patient acceptable symptom state (PASS) in patients with ankylosing spondylitis. Rheumatol Int 32:361–368
Doward LC, Spoorenberg A, Cook SA, Whalley D, Helliwell PS, Kay LJ, McKenna SP, Tennant A, van der Heijde D, Chamberlain MA (2003) Development of the ASQoL: a quality of life instrument specific to ankylosing spondylitis. Ann Rheum Dis 62(1):20–26
Marks SH, Barnett M, Calin A (1983) Ankylosing spondylitis in women and men: a case–control study. J Rheumatol 10(4):624–628
Lee W, Reveille JD, Weisman MH (2008) Women with ankylosing spondylitis: a review. Arthritis Rheum 59(3):449–454
Will R, Edmunds L, Elswood J, Calin A (1990) Is there sexual inequality in ankylosing spondylitis? A study of 498 women and 1202 men. J Rheumatol 17(12):1649–1652
Nazarinia MA, Ghaffarpasand F, Heiran HR, Habibagahi Z (2009) Pattern of ankylosing spondylitis in an Iranian population of 98 patients. Mod Rheumatol 19(3):309–315
Bodur H, Ataman S, Bugdayci DS, Rezvani A, Nas K, Uzunca K, Emlakcioglu E, Karatepe AG, Durmus B, Sezgin M, Ayhan F, Yazgan P, Duruoz T, Yener M, Gurgan A, Kirnap M, Cakar E, Altan L, Soydemir R, Capkin E, Tekeoglu I, Aydin G, Gunendi Z, Nacir B, Salli A, Ozturk C, Memis A, Turan Y, Kozanoglu E, Sivrioglu K (2012) Description of the registry of patients with ankylosing spondylitis in Turkey: TRASD-IP. Rheumatol Int 32(1):169–176
Lee CH, Lee MS, Kang KY, Mun SJ, Kim JM, Yun HS, Kwak SG, Ju JH, Park KS, Kim H-Y, Park S-H (2012) Gender differences in clinical features and anti-TNF agent use in Korean ankylosing spondylitis patients. J Rheum Dis 19(3):132–137
Aggarwal R, Malaviya AN (2009) Clinical characteristics of patients with ankylosing spondylitis in India. Clin Rheumatol 28(10):1199–1205
Zeng QY (2003) Ankylosing spondylitis in Shantou, China: 15 years' clinical experience. J Rheumatol 30(8):1816–1821
Vliet Vlieland TP, Buitenhuis NA, van Zeben D, Vandenbroucke JP, Breedveld FC, Hazes JM (1994) Sociodemographic factors and the outcome of rheumatoid arthritis in young women. Ann Rheum Dis 53(12):803–806
Salaffi F, Carotti M, Gasparini S, Intorcia M, Grassi W (2009) The health-related quality of life in rheumatoid arthritis, ankylosing spondylitis, and psoriatic arthritis: a comparison with a selected sample of healthy people. Health Qual Life Outcomes 7:25
Dernis E, Said-Nahal R, D'Agostino MA, Aegerter P, Dougados M, Breban M (2009) Recurrence of spondylarthropathy among first-degree relatives of patients: a systematic cross-sectional study. Ann Rheum Dis 68(4):502–507
Stone M, Warren RW, Bruckel J, Cooper D, Cortinovis D, Inman RD (2005) Juvenile-onset ankylosing spondylitis is associated with worse functional outcomes than adult-onset ankylosing spondylitis. Arthritis Rheum 53(3):445–451
Robinson PC, Brown MA (2012) The genetics of ankylosing spondylitis and axial spondyloarthritis. Rheum Dis Clin N Am 38(3):539–553
Hill HF, Hill AG, Bodmer JG (1976) Clinical diagnosis of ankylosing spondylitis in women and relation to presence of HLA-B27. Ann Rheum Dis 35(3):267–270
de Carvalho HM, Bortoluzzo AB, Goncalves CR, da Silva JA, Ximenes AC, Bertolo MB, Ribeiro SL, Keiserman M, Menin R, Skare TL, Carneiro S, Azevedo VF, Vieira WP, Albuquerque EN, Bianchi WA, Bonfiglioli R, Campanholo C, Costa IP, Duarte AP, Gavi MB, Kohem CL, Leite NH, Lima SA, Meirelles ES, Pereira IA, Pinheiro MM, Polito E, Resende GG, Rocha FA, Santiago MB, Sauma Mde F, Sampaio-Barros PD (2012) Gender characterization in a large series of Brazilian patients with spondyloarthritis. Clin Rheumatol 31(4):687–695
Singh G, Lawrence A, Agarwal V, Misra R, Aggarwal A (2008) Higher prevalence of extra-articular manifestations in ankylosing spondylitis with peripheral arthritis. J Clin Rheumatol 14(5):264–266
Zeboulon N, Dougados M, Gossec L (2008) Prevalence and characteristics of uveitis in the spondyloarthropathies: a systematic literature review. Ann Rheum Dis 67(7):955–959
Linder R, Hoffmann A, Brunner R (2004) Prevalence of the spondyloarthritides in patients with uveitis. J Rheumatol 31(11):2226–2229
Tay-Kearney ML, Schwam BL, Lowder C, Dunn JP, Meisler DM, Vitale S, Jabs DA (1996) Clinical features and associated systemic diseases of HLA-B27 uveitis. Am J Ophthalmol 121(1):47–56
Calin A, Elswood J, Rigg S, Skevington SM (1988) Ankylosing spondylitis–an analytical review of 1500 patients: the changing pattern of disease. J Rheumatol 15(8):1234–1238
Zochling J (2011) Measures of symptoms and disease status in ankylosing spondylitis: Ankylosing Spondylitis Disease Activity Score (ASDAS), Ankylosing Spondylitis Quality of Life Scale (ASQoL), Bath Ankylosing Spondylitis Disease Activity Index (BASDAI), Bath Ankylosing Spondylitis Functional Index (BASFI), Bath Ankylosing Spondylitis Global Score (BAS-G), Bath Ankylosing Spondylitis Metrology Index (BASMI), Dougados Functional Index (DFI), and Health Assessment Questionnaire for the Spondylarthropathies (HAQ-S). Arthritis Care Res (Hoboken) 63(Suppl 11):S47–S58
Jimenez-Balderas FJ, Mintz G (1993) Ankylosing spondylitis: clinical course in women and men. J Rheumatol 20(12):2069–2072
Ibn Yacoub Y, Amine B, Laatiris A, Hajjaj-Hassouni N (2012) Gender and disease features in Moroccan patients with ankylosing spondylitis. Clin Rheumatol 31(2):293–297
Jung YO, Kim I, Kim S, Suh CH, Park HJ, Park W, Kwon SR, Jeong JC, Lee YJ, Ryu HJ, Park YB, Lee J, Lee YH, Seo YI, Chung WT, Hong SJ, Hong YS, Baek HJ, Choi HJ, Kang HJ, Lee CH, Kim SH, Kim HA (2010) Clinical and radiographic features of adult-onset ankylosing spondylitis in Korean patients: comparisons between males and females. J Korean Med Sci 25(4):532–535
Acknowledgments
This study was supported by a grant from Tehran University of Medical Sciences (TUMS), Tehran, Iran. We thank the Rheumatology Research Center and Iranian AS society for their valuable collaborations.
Disclosures
None
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Shahlaee, A., Mahmoudi, M., Nicknam, M.H. et al. Gender differences in Iranian patients with ankylosing spondylitis. Clin Rheumatol 34, 285–293 (2015). https://doi.org/10.1007/s10067-013-2439-4
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10067-013-2439-4